ArticleMolecular cancer therapeutics2025

First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas.

Kimberley S Samkoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.